DMPK 編集委員

Editor in chief

	Prof. Kan Chiba, Ph.D. Chiba University, Chiba

Associate Editors

	Toshihiko Ikeda，Ph.D. Association for Promoting Drug Development, Tokyo		Prof. Mikihisa Takano, Ph.D. Hiroshima University, Hiroshima
	Ryosei Kawai, Ph.D. Novartis Institute for Biomedical Research, Inc., Cambridge, U.S.A.		Prof. Hiroshi Yamazaki, Ph.D. Showa Pharmaceutical University, Tokyo
	Prof. Emi Nakashima, Ph.D. Kyoritsu University of Pharmacy, Tokyo		Prof. Hideyuki Yamada, Ph.D. Kyushu University, Fukuoka
	Prof.Shogo Ozawa, Ph.D. Iwate Medical University, Iwate		Prof. Hiroaki Yuasa, Ph.D. Nagoya City University, Nagoya
	Ken-ichi Sudo, Ph.D. Daiichi Sankyo Co., Ltd., Tokyo

Editorial Advisory Board

Young-Nam Cha (Inha University, Incheon, Korea)
Masato Chiba (Banyu Pharmaceutical Co., Ltd., Tsukuba)
Stephen Duffull (University of Otago, New Zealand)
Yukiya Hashimoto (University of Toyama, Toyama)
Kazutaka Higaki (Okayama University, Okayama)
Masakiyo Hosokawa (Chiba Institute of Science, Chiba)
Jin-ding Huang (National Cheng Kung Univ., Taiwan)
Ichiro Ieiri (Kyushu University, Fukuoka)
Susumu Imaoka (Kwansei Gakuin University, Hyogo)
Tatsuhiro Ishida (The University of Tokushima, Tokushima)
Kiyomi Ito (Hoshi University, Tokyo)
Tomoo Itoh (Kitasato University, Tokyo)
Kazuhide Iwasaki (Pfizer Inc., Chita-gun, Aichi)
Hidefumi Kasai (Bellsystem24, Tokyo)
Motohiro Kato (Chugai Pharmaceutical Co.,Ltd., Shizuoka)
Yukio Kato (Kanazawa University, Kanazawa)
Toshiyuki Kume (Tanabe Seiyaku Co, Ltd., Saitama)
Hiroyuki Kusuhara (Tokyo University, Tokyo)
Edmund Jon Deoon Lee (National University of Singapore, Singapore)
Jiunn.H. Lin (Merck & Co., Inc., PA, USA)
Philip J. Lowe (Novartis Pharmaceuticals AG, Basel, Switzerland)
Takashi Mizuma (Tokyo University of Pharmacy and Life Sciences, Tokyo)
Teruo Murakami (Hiroshima International University, Hiroshima)
Kiyoshi Nagata (Tohoku Pharmaceutical University, Sendai)
Shinsaku Naito (Otsuka Pharmaceutical Factory, Inc., Tokushima)
Miki Nakajima (Kanazawa University, Kanazawa)
Takuo Ogihara (Takasaki University of Health and Welfare, Gunma)
R. Scott Obach (Pfizer Inc., CT, USA)
Young-Ki Paik (Yonsei University, Korea)
M. S. Roberts (Princess Alexandra Hospital, Univ. of Queensland, Australia)
Amin Rostami-Hodjegan (University of Sheffield, UK)
Chang-Koo Shim (Seoul National University, College of Pharmacy, Seoul, Korea)
Wichittra Tassaneeyakul (Departmant of Pharmacology, Facculty of Medicine, Khon kaen University, Thailand)
Akira Yamamoto (Kyoto Pharmaceutical University, Kyoto)
Fumiyoshi Yamashita (Kyoto University, Kyoto)
Bingfang Yan (University of Rhode Island, USA)
Masato Yasuhara (Tokyo Medical and Dental University, Tokyo)

Senior Advisor

Mitsuru Hashida (Kyoto University, Kyoto)
Masahiro Hayashi (School of Pharmacy, Tokyo University of Pharmacy & Life Science, Tokyo)
Nick Holford (University of Auckland, Auckland, New Zealand)
Ken-ichi Inui (Kyoto University Hospital, Kyoto)
William J. Jusko (State Univ. of New York at Buffalo, New York, USA)
Tetsuya Kamataki (Tokyo Institute of Technology and Riken, Yokohama)
Akira Tsuji (Kanazawa University, Kanazawa)
Yasushi Yamazoe (Tohoku University, Sendai)